Discovering endophenotypes for major depression

Neuropsychopharmacology

Volumn 29, Issue 10, 2004, Pages 1765-1781

  Hasler, Gregor ^a   Drevets, Wayne C ^a   Manji, Husseini K ^a   Charney, Dennis S ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Biological psychiatry; Classification; Depression; Epidemiology; Genetics; Phenotype

Indexed keywords

BIOLOGICAL MARKER; CORTICOTROPIN; DOPAMINE; HYDROCORTISONE; NORADRENALIN; SEROTONIN;

ANHEDONIA; AUTONOMIC NEUROPATHY; BRAIN DYSFUNCTION; CATECHOLAMINERGIC SYSTEM; CIRCADIAN RHYTHM; COGNITIVE DEFECT; DISEASE CLASSIFICATION; EMOTIONAL DISORDER; GENETIC HETEROGENEITY; HERITABILITY; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LEARNING DISORDER; MAJOR DEPRESSION; MEDICAL LITERATURE; MEMORY DISORDER; MOOD DISORDER; NONHUMAN; PARASOMNIA; PHENOTYPE; PRIORITY JOURNAL; PSYCHOMOTOR RETARDATION; REM SLEEP; RESTLESSNESS; REVIEW; REWARD; SEROTONINERGIC SYSTEM; SIGNAL TRANSDUCTION; STRESS;

AFFECT; BRAIN; BRAIN CHEMISTRY; DEPRESSIVE DISORDER, MAJOR; HUMANS; LEARNING DISORDERS; MEMORY DISORDERS; PHENOTYPE; PSYCHOMOTOR PERFORMANCE; REWARD; SIGNAL TRANSDUCTION; STRESS, PSYCHOLOGICAL;

EID: 5044228631     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1300506     Document Type: Review

References (195)

1. Almasy L, Blangero J (2001). Endophenotypes as quantitative risk factors for psychiatric disease: rationale and study design. Am J Med Genet 105: 42-44.
2. Angst J, Dobler-Mikola A (1984). The Zurich study. II. The continuum from normal to pathological depressive mood swings. Eur Arch Psychiatry Clin Neurosci 234: 21-29.
3. Angst J, Dobler-Mikola A (1985). The Zurich study. VI. A continuum from depression to anxiety disorders? Eur Arch Psychiatry Clin Neurosci 235: 179-186.
4. Angst J, Dobler-Mikola A, Binder J (1984). The Zurich Study - a prospective epidemiological study of depressive, neurotic and psychosomatic syndromes. Eur Arch Psychiatry Clin Neurosci 234: 13-20.
5. Angst J, Merikangas KR (2001). Multi-dimensional criteria for the diagnosis of depression. J Affect Disord 62: 7-15.
6. Angst J, Sellaro R, Merikangas KR (2000). Depressive spectrum diagnoses. Compr Psychiatry 41: 39-47.
7. Angst J, Vollrath M, Merikangas K, Ernst C (1990). Comorbidity of anxiety and depression in the Zurich Cohort Study of Young Adults. In: Maser JD, Cloninger CR (eds). Comorbidity of Mood and Anxiety Disorders. American Psychiatric Press: Washington, DC. pp 123-137.
8. Baghai TC, Schule C, Zwanzger P, Zill P, Ella R, Eser D et al (2003). Influence of a functional polymorphism within the angiotensin I-converting enzyme gene on partial sleep deprivation in patients with major depression. Neurosci Lett 339: 223-226.
9. Bakshi VP, Kalin NH (2002). Animal models and endophenotypes of anxiety and stress disorders In: Davis KL, Charney DS, Coyle JT, Nemeroff CB (eds). Neuropsychopharmacology: The Fifth Generation of Progress. Lippincott Williams & Wilkins: Philadelphia, PA. pp 883-900.
10. Barch DM, Sheline YI, Csernansky JG, Snyder AZ (2003). Working memory and prefrontal cortex dysfunction: specificity to schizophrenia compared with major depression. Biol Psychiatry 53: 376-384.
11. Beck AT (1967). Depression: Clinical, Experimental and Theoretical Aspects. Harper & Row: New York.
12. Belanoff JK, Rothschild AJ, Cassidy F, DeBattista C, Baulieu EE, Schold C et al (2002). An open label trial of C-1073 (mifepristone) for psychotic major depression. Biol Psychiatry 52: 386-392.
13. Bell C, Abrams J, Nutt D (2001). Tryptophan depletion and its implications for psychiatry. Br J Psychiatry 178: 399-405.
14. Benedetti F, Serretti A, Colombo C, Campori E, Barbini B, di Bella D et al (1999). Influence of a functional polymorphism within the promoter of the serotonin transporter gene on the effects of total sleep deprivation in bipolar depression. Am J Psychiatry 156: 1450-1452.
15. Benkelfat C, Ellenbogen MA, Dean P, Palmour RM, Young SN (1994). Mood-lowering effect of tryptophan depletion. Enhanced susceptibility in young men at genetic risk for major affective disorders. Arch Gen Psychiatry 51: 687-697.
16. Berman KF, Doran AR, Pickar D, Weinberger DR (1993). Is the mechanism of prefrontal hypofunction in depression the same as in schizophrenia? Regional cerebral blood flow during cognitive activation. Br J Psychiatry 162: 183-192.
17. Berman RM, Narasimhan M, Miller HL, Anand A, Cappiello A, Oren DA et al (1999). Transient depressive relapse induced by catecholamine depletion: potential phenotypic vulnerability marker? Arch Gen Psychiatry 56: 395-403.
18. Bhagwagar Z, Montgomery AJ, Grasby PM, Cowen PJ (2003). Lack of effect of a single dose of hydrocortisone on serotonin(1A) receptors in recovered depressed patients measured by positron emission tomography with [(11)C]WAY-100635. Biol Psychiatry 54: 890-895.
19. Bhagwagar Z, Rabiner EA, Sargent PA, Grasby PM, Cowen PJ (2004). Persistent reduction in brain serotonin(1A) receptor binding in recovered depressed men measured by positron emission tomography with [(11)C]WAY-100635. Mol Psychiatry 9: 386-392.
20. Blumberg HP, Leung HC, Skudlarski P, Lacadie CM, Fredericks CA, Harris BC et al (2003). A functional magnetic resonance imaging study of bipolar disorder: state- and trait-related dysfunction in ventral prefrontal cortices. Arch Gen Psychiatry 60: 601-609.
21. Boivin DB, Czeisler CA, Dijk DJ, Duffy JF, Folkard S, Minors DS et al (1997). Complex interaction of the sleep-wake cycle and circadian phase modulates mood in healthy subjects. Arch Gen Psychiatry 54: 145-152.
22. Bondy B, Baghai TC, Zill P, Bottlender R, Jaeger M, Minov C et al (2002). Combined action of the ACE D- and the G-protein beta3 T-allele in major depression: a possible link to cardiovascular disease? Mol Psychiatry 7: 1120-1126.
23. Botteron KN, Raichle ME, Heath AC, Price A, Sternhell KE, Singer TM et al (1999). An epidemiological twin study of prefrontal neuromorphometry in early onset depression. Biol Psychiatry 45: 59S.
24. Bremner JD, Innis RB, Salomon RM, Staib LH, Ng CK, Miller HL et al (1997). Positron emission tomography measurement of cerebral metabolic correlates of tryptophan depletion-induced depressive relapse. Arch Gen Psychiatry 54: 364-374.
25. Bremner JD, Vythilingam M, Chin KN, Vermetten E, Nazeer A, Oren D et al (2003). Regional brain metabolic correlates of alpha-methylparatyrosine-induced depressive symptoms. JAMA 289: 3125-3134.
26. Brook DW, Brook JS, Zhang C, Cohen P, Whiteman M (2002). Drug use and the risk of major depressive disorder, alcohol dependence, and substance use disorders. Arch Gen Psychiatry 59: 1039-1044.
27. Brunson KL, Eghbal-Ahmadi M, Bender R, Chen Y, Baram TZ (2001). Long-term, progressive hippocampal cell loss and dysfunction induced by early-life administration of corticotropin-releasing hormone reproduce the effects of early-life stress. Proc Natl Acad Sci USA 98: 8856-8861.
28. Buchsbaum MS, Wu J, Siegel BV, Hackett E, Trenary M, Abel L et al (1997). Effect of sertraline on regional metabolic rate in patients with affective disorder. Biol Psychiatry 41: 15-22.
29. Bunney WE, Bunney BG (2000). Molecular clock genes in man and lower animals: possible implications for circadian abnormalities in depression. Neuropsychopharmacology 22: 335-345.
30. Burt DB, Zembar MJ, Niederehe G (1995). Depression and memory impairment: a meta-analysis of the association, its pattern, and specificity. Psychol Bull 117: 285-305.
31. Caspi A, McClay J, Moffitt TE, Mill J, Martin J, Craig IW et al (2002). Role of genotype in the cycle of violence in maltreated children. Science 297: 851-854.
32. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H et al (2003). Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301: 386-389.
33. Charney DS (1998). Monoamine dysfunction and the pathophysiology and treatment of depression. J Clin Psychiatry 59: 11-14.
34. Charney DS, Barlow DH, Botteron KN, Cohen JD, Goldman D, Gur RC et al (2002). Neuroscience research agenda to guide development of a pathophysiologically based classification system. In: Kupfer DJ, First MB, Regier DA (eds). A Research Agenda for DSM-V. American Psychiatric Association: Washington, DC. pp 31-83.
35. Charney DS, Drevets WC (2002). The neurobiological basis of anxiety disorders. In: Davis KL, Charney DS, Coyle JT, Nemeroff CB (eds). Neuropsychopharmacology: The Fifth Generation of Progress. Lippincott Williams & Wilkins: Philadelphia, PA. pp 901-930.
36. Charney DS, Menkes DB, Heninger GR (1981). Receptor sensitivity and the mechanism of action of antidepressant treatment. Implications for the etiology and therapy of depression. Arch Gen Psychiatry 38: 1160-1180.
37. Chen AC, Shirayama Y, Shin KH, Neve RL, Duman RS (2001). Expression of the cAMP response element binding protein (CREB) in hippocampus produces an antidepressant effect. Biol Psychiatry 49: 753-762.
38. Claes S, Villafuerte S, Forsgren T, Sluijs S, Del-Favero J, Adolfsson R et al (2003). The corticotropin-releasing hormone binding protein is associated with major depression in a population from Northern Sweden. Biol Psychiatry 54: 867-872.
39. Comings DE, Wu S, Rostamkhani M, McGue M, Iacono WG, MacMurray JP (2002). Association of the muscarinic cholinergic 2 receptor (CHRM2) gene with major depression in women. Am J Med Genet 114: 527-529.
40. Coppen A, Eccleston EG, Peet M (1973). Total and free tryptophan concentration in the plasma of depressive patients. Lancet 2: 60-63.
41. Costa Jr PT, McCrae RR (1988). Personality in adulthood: a six-year longitudinal study of self-reports and spouse ratings on the NEO Personality Inventory. J Pers Soc Psychol 54: 853-863.
42. Costello EJ, Pine DS, Hammen C, March JS, Plotsky PM, Weissman MM et al (2002). Development and natural history of mood disorders. Biol Psychiatry 52: 529-542.
43. Damasio AR, Tranel D, Damasio H (1990). Individuals with sociopathic behavior caused by frontal damage fail to respond autonomically to social stimuli. Behav Brain Res 41: 81-94.
44. de Kloet RE (2003). Hormones, brain and stress. Endocr Regul 37: 51-68.
45. Delgado PL, Miller HL, Salomon RM, Licinio J, Krystal JH, Moreno FA et al (1999). Tryptophan-depletion challenge in depressed patients treated with desipramine or fluoxetine: implications for the role of serotonin in the mechanism of antidepressant action. Biol Psychiatry 46: 212-220.
46. Delgado PL, Price LH, Miller HL, Salomon RM, Aghajanian GK, Heninger GR et al (1994). Serotonin and the neurobiology of depression. Effects of tryptophan depletion in drug-free depressed patients. Arch Gen Psychiatry 51: 865-874.
47. Drevets WC (2000). Neuroimaging studies of mood disorders. Biol Psychiatry 48: 813-829.
48. Drevets WC (2001). Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders. Curr Opin Neurobiol 11: 240-249.
49. Drevets WC, Frank E, Price JC, Kupfer DJ, Greer PJ, Mathis C (2000). Serotonin type-1A receptor imaging in depression. Nucl Med Biol 27: 499-507.
50. Drevets WC, Frank E, Price JC, Kupfer DJ, Holt D, Greer PJ et al (1999). PET imaging of serotonin 1A receptor binding in depression. Biol Psychiatry 46: 1375-1387.
51. Drevets WC, Price JL, Simpson Jr JR, Todd RD, Reich T, Vannier M et al (1997). Subgenual prefrontal cortex abnormalities in mood disorders. Nature 386: 824-827.
52. Drevets WC, Raichle ME (1998). Reciprocal suppression of regional cerebral blood flow during emotional versus higher cognitive processes: implications for interactions between emotion and cognition. Cognition Emotion 12: 353-385.
53. Drevets WC, Sills R, Nugent AC, Bain E, Neumeister A, Price J et al (2004). Volumetric assessment of the amygdala in mood disorders using high resolution, 3T MRI. Biol Psychiatry 55: 182S.
54. Drevets WC, Videen TO, Price JL, Preskorn SH, Carmichael ST, Raichle ME (1992). A functional anatomical study of unipolar depression. J Neurosci 12: 3628-3641.
55. Dryman A, Eaton WW (1991). Affective symptoms associated with the onset of major depression in the community: findings from the US National Institute of Mental Health Epidemiologic Catchment Area Program. Acta Psychiatr Scand 84: 1-5.
56. Duncan Jr WC (1996). Circadian rhythms and the pharmacology of affective illness. Pharmacol Ther 71: 253-312.
57. Dwivedi Y, Rizavi HS, Conley RR, Roberts RC, Tamminga CA, Pandey GN (2003). Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in post-mortem brain of suicide subjects. Arch Gen Psychiatry 60: 804-815.
58. Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, Straub RE et al (2001). Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci USA 98: 6917-6922.
59. Egan MF, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, Bertolino A et al (2003). The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112: 257-269.
60. Elliott R, Rubinsztein JS, Sahakian BJ, Dolan RJ (2002). The neural basis of mood-congruent processing biases in depression. Arch Gen Psychiatry 59: 597-604.
61. Fanous A, Gardner CO, Prescott CA, Cancro R, Kendler KS (2002). Neuroticism, major depression and gender: a population-based twin study. Psychol Med 32: 719-728.
62. Farmer A, Mahmood A, Redman K, Harris T, Sadler S, McGuffin P (2003). A sib-pair study of the Temperament and Character Inventory scales in major depression. Arch Gen Psychiatry 60: 490-496.
63. Fawcett J, Clark DC, Scheftner WA, Gibbons RD (1983). Assessing anhedonia in psychiatric patients. Arch Gen Psychiatry 40: 79-84.
64. Francis DD, Meaney MJ (1999). Maternal care and the development of stress responses. Curr Opin Neurobiol 9: 128-134.
65. Gass P, Kretz O, Wolfer DP, Berger S, Tronche F, Reichardt HM et al (2000). Genetic disruption of mineralocorticoid receptor leads to impaired neurogenesis and granule cell degeneration in the hippocampus of adult mice. EMBO Rep 1: 447-451.
66. Geiman TM, Robertson KD (2002). Chromatin remodeling, histone modifications, and DNA methylation - how does it all fit together? J Cell Biochem 87: 117-125.
67. Gesing A, Bilang-Bleuel A, Droste SK, Linthorst AC, Holsboer F, Reul JM (2001). Psychological stress increases hippocampal mineralocorticoid receptor levels: involvement of corticotropin-releasing hormone. J Neurosci 21: 4822-4829.
68. Giasson BI, Lee VM (2003). Are ubiquitination pathways central to Parkinson's disease? Cell 114: 1-8.
69. Giles DE, Jarrett RB, Rush AJ, Biggs MM, Roffwarg HP (1993). Prospective assessment of electroencephalographic sleep in remitted major depression. Psychiatry Res 46: 269-284.
70. Giles DE, Kupfer DJ, Rush AJ, Roffwarg HP (1998). Controlled comparison of electrophysiological sleep in families of probands with unipolar depression. Am J Psychiatry 155: 192-199.
71. Gillard ER, Dang DQ, Stanley BG (1993). Evidence that neuropep-tide Y and dopamine in the perifornical hypothalamus interact antagonistically in the control of food intake. Brain Res 628: 128-136.
72. Glazier AM, Nadeau JH, Aitman TJ (2002). Finding genes that underlie complex traits. Science 298: 2345-2349.
73. Gold PW, Drevets WC, Charney DS (2002). New insights into the role of cortisol and the glucocorticoid receptor in severe depression. Biol Psychiatry 52: 381-385.
74. Gold PW, Loriaux DL, Roy A, Kling MA, Calabrese JR, Kellner CH et al (1986). Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. Pathophysiologic and diagnostic implications. N Engl J Med 314: 1329-1335.
75. Gottesman II, Gould TD (2003). The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 160: 636-645.
76. Gottesman II, Shields J (1973). Genetic theorizing and schizophrenia. Br J Psychiatry 122: 15-30.
77. Graves LA, Hellman K, Veasey S, Blendy JA, Pack AI, Abel T (2003). Genetic evidence for a role of CREB in sustained cortical arousal. J Neurophysiol 90: 1152-1159.
78. Griens AM, Jonker K, Spinhoven P, Blom MB (2002). The influence of depressive state features on trait measurement. J Affect Disord 70: 95-99.
79. Gross C, Zhuang X, Stark K, Ramboz S, Oosting R, Kirby L et al (2002). Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult. Nature 416: 396-400.
80. Hagerty BM, Williams RA, Liken M (1997). Prodromal symptoms of recurrent major depressive episodes: a qualitative analysis. Am J Orthopsychiatry 67: 308-314.
81. Hammen C, Marks T, Mayol A, deMayo R (1985). Depressive self-schemas, life stress, and vulnerability to depression. J Abnorm Psychol 94: 308-319.
82. Hariri AR, Mattay VS, Tessitore A, Kolachana B, Fera F, Goldman D et al (2002). Serotonin transporter genetic variation and the response of the human amygdala. Science 297: 400-403.
83. Hariri AR, Weinberger DR (2003). Imaging genomics. Br Med Bull 65: 259-270.
84. Hasler G, Pine DS, Gamma A, Milos G, Ajdacic V, Eich D et al (2004). The association between psychopathology and being overweight. Psychol Med (in press).
85. Heim C, Nemeroff CB (2001). The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies. Biol Psychiatry 49: 1023-1039.
86. Heuser I, Yassouridis A, Holsboer F (1994). The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders. J Psychiatr Res 28: 341-356.
87. Hirayasu Y, Shenton ME, Salisbury DF, Kwon JS, Wible CG, Fischer IA et al (1999). Subgenual cingulate cortex volume in first-episode psychosis. Am J Psychiatry 156: 1091-1093.
88. Holsboer F, Lauer CJ, Schreiber W, Krieg JC (1995). Altered hypothalamic-pituitary-adrenocortical regulation in healthy subjects at high familial risk for affective disorders. Neuroendocrinology 62: 340-347.
89. Jang KL, Livesley WJ, Vernon PA (1996). Heritability of the big five personality dimensions and their facets: a twin study. J Pers 64: 577-591.
90. Karten YJ, Nair SM, van Essen L, Sibug R, Joels M (1999). Long-term exposure to high corticosterone levels attenuates serotonin responses in rat hippocampal CA1 neurons. Proc Natl Acad Sci USA 96: 13456-13461.
91. Keating M, Atkinson D, Dunn C, Timothy K, Vincent GM, Leppert M (1991). Linkage of a cardiac arrhythmia, the long QT syndrome, and the Harvey ras-1 gene. Science 252: 704-706.
92. Keating MT, Sanguinetti MC (2001). Molecular and cellular mechanisms of cardiac arrhythmias. Cell 104: 569-580.
93. Kegeles LS, Malone KM, Slifstein M, Ellis SP, Xanthopoulos E, Keilp JG et al (2003). Response of cortical metabolic deficits to serotonergic challenge in familial mood disorders. Am J Psychiatry 160: 76-82.
94. Kendell RE (1989). Clinical validity. Psychol Med 19: 45-55.
95. Kendler KS, Davis CG, Kessler RC (1997). The familial aggregation of common psychiatric and substance use disorders in the National Comorbidity Survey: a family history study. Br J Psychiatry 170: 541-548.
96. Kendler KS, Eaves LJ, Walters EE, Neale MC, Heath AC, Kessler RC (1996). The identification and validation of distinct depressive syndromes in a population-based sample of female twins. Arch Gen Psychiatry 53: 391-399.
97. Kendler KS, Gardner CO, Prescott CA (1999). Clinical characteristics of major depression that predict risk of depression in relatives. Arch Gen Psychiatry 56: 322-327.
98. Kendler KS, Thornton LM, Prescott CA (2001). Gender differences in the rates of exposure to stressful life events and sensitivity to their depressogenic effects. Am J Psychiatry 158: 587-593.
99. Klaassen T, Riedel WJ, Deutz NE, Van Praag HM (2002). Mood congruent memory bias induced by tryptophan depletion. Psychol Med 32: 167-172.
100. Klein DF (1974). Endogenomorphic depression. A conceptual and terminological revision. Arch Gen Psychiatry 31: 447-454.
101. Koed K, Linnet K (2000). Opposing changes in serotonin and norepinephrine transporter mRNA levels after serotonin depletion. Eur Neuropsychopharmacol 10: 501-509.
102. Koper JW, Stolk RP, de Lange P, Huizenga NA, Molijn GJ, Pols HA et al (1997). Lack of association between five polymorphisms in the human glucocorticoid receptor gene and glucocorticoid resistance. Hum Genet 99: 663-668.
103. Koschack J, Hoschel K, Irle E (2003). Differential impairments of facial affect priming in subjects with acute or partially remitted major depressive episodes. J Nerv Ment Dis 191: 175-181.
104. Kuroda Y, Watanabe Y, Albeck DS, Hastings NB, McEwen BS (1994). Effects of adrenalectomy and type I or type II glucocorticoid receptor activation on 5-HT1A and 5-HT2 receptor binding and 5-HT transporter mRNA expression in rat brain. Brain Res 648: 157-161.
105. Lambert G, Johansson M, Agren H, Friberg P (2000). Reduced brain norepinephrine and dopamine release in treatment-refractory depressive illness: evidence in support of the catecholamine hypothesis of mood disorders. Arch Gen Psychiatry 57: 787-793.
106. Landro NI, Stiles TC, Sletvold H (2001). Neuropsychological function in nonpsychotic unipolar major depression. Neuropsychiatry Neuropsychol Behav Neurol 14: 233-240.
107. Lemonde S, Turecki G, Bakish D, Du L, Hrdina PD, Bown CD et al (2003). Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide. J Neurosci 23: 8788-8799.
108. Linkowski P, Van Onderbergen A, Kerkhofs M, Bosson D, Mendlewicz J, Van Cauter E (1993). Twin study of the 24-h cortisol profile: evidence for genetic control of the human circadian clock. Am J Physiol 264: E173-E181.
109. Liotti M, Mayberg HS, McGinnis S, Brannan SL, Jerabek P (2002). Unmasking disease-specific cerebral blood flow abnormalities: mood challenge in patients with remitted unipolar depression. Am J Psychiatry 159: 1830-1840.
110. Loas G, Boyer P, Legrand A (1999). Anhedonia in the deficit syndrome of schizophrenia. Psychopathology 32: 207-219.
111. Lopez JF, Chalmers DT, Little KY, Watson SJ (1998). A.E. Bennett Research Award. Regulation of serotonin1A, glucocorticoid, and mineralocorticoid receptor in rat and human hippocampus: implications for the neurobiology of depression. Biol Psychiatry 43: 547-573.
112. Luciano M, Wright MJ, Smith GA, Geffen GM, Geffen LB, Martin NG (2003). Genetic covariance between processing speed and IQ In: Plomin R, DeFries JC, Craig IW, McGuffin P (eds). Behavioral Genetics in the Postgenomic Era. American Psychological Association: Washington, DC. pp 163-181.
113. Lyons DM, Yang C, Sawyer-Glover AM, Moseley ME, Schatzberg AF (2001). Early life stress and inherited variation in monkey hippocampal volumes. Arch Gen Psychiatry 58: 1145-1151.
114. MacQueen GM, Campbell S, McEwen BS, Macdonald K, Amano S, Joffe RT et al (2003). Course of illness, hippocampal function, and hippocampal volume in major depression. Proc Natl Acad Sci USA 100: 1387-1392.
115. MacQueen GM, Galway TM, Hay J, Young LT, Joffe RT (2002). Recollection memory deficits in patients with major depressive disorder predicted by past depressions but not current mood state or treatment status. Psychol Med 32: 251-258.
116. Malhotra AK, Kestler LJ, Mazzanti C, Bates JA, Goldberg T, Goldman D (2002). A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition. Am J Psychiatry 159: 652-654.
117. Manji HK, Drevets WC, Charney DS (2001). The cellular neurobiology of depression. Nat Med 7: 541-547.
118. Manji HK, Duman RS (2001). Impairments of neuroplasticity and cellular resilience in severe mood disorders: implications for the development of novel therapeutics. Psychopharmacol Bull 35: 5-49.
119. Manji HK, Gottesman II, Gould TD (2003a). Signal transduction and genes-to-behaviors pathways in psychiatric diseases. Sci STKE 2003: pe49.
120. Manji HK, Quiroz JA, Sporn J, Payne JL, Denicoff K, N AG et al (2003b). Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression. Biol Psychiatry 53: 707-742.
121. Mattay VS, Goldberg TE, Fera F, Hariri AR, Tessitore A, Egan MF et al (2003). Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine. Proc Natl Acad Sci USA 100: 6186-6191.
122. Mayberg HS, Liotti M, Brannan SK, McGinnis S, Mahurin RK, Jerabek PA et al (1999). Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. Am J Psychiatry 156: 675-682.
123. McEwen BS (1999). Stress and hippocampal plasticity. Annu Rev Neurosci 22: 105-122.
124. McMahon SD, Grant KE, Compas BE, Thurm AE, Ey S (2003). Stress and psychopathology in children and adolescents: is there evidence of specificity? J Child Psychol Psychiatry 44: 107-133.
125. Meguid MM, Fetissov SO, Varma M, Sato T, Zhang L, Laviano A et al (2000). Hypothalamic dopamine and serotonin in the regulation of food intake. Nutrition 16: 843-857.
126. Mendels J, Frazer A (1974). Brain biogenic amine depletion and mood. Arch Gen Psychiatry 30: 447-451.
127. Merikangas KR, Zhang H, Avenevoli S, Acharyya S, Neuenschwander M, Angst J (2003). Longitudinal trajectories of depression and anxiety in a prospective community study: the Zurich Cohort Study. Arch Gen Psychiatry 60: 993-1000.
128. Miller HL, Delgado PL, Salomon RM, Berman R, Krystal JH, Heninger GR et al (1996a). Clinical and biochemical effects of catecholamine depletion on antidepressant-induced remission of depression. Arch Gen Psychiatry 53: 117-128.
129. Miller HL, Delgado PL, Salomon RM, Heninger GR, Charney DS (1996b). Effects of alpha-methyl-para-tyrosine (AMPT) in drug-free depressed patients. Neuropsychopharmacology 14: 151-157.
130. Mitchell P, Hadzi-Pavlovic D, Parker G, Hickie I, Wilhelm K, Brodaty H et al (1996). Depressive psychomotor disturbance, cortisol, and dexamethasone. Biol Psychiatry 40: 941-950.
131. Mizoguchi K, Ishige A, Aburada M, Tabira T (2003). Chronic stress attenuates glucocorticoid negative feedback: involvement of the prefrontal cortex and hippocampus. Neuroscience 119: 887-897.
132. Modell S, Huber J, Holsboer F, Lauer CJ (2003). The Munich Vulnerability Study on Affective Disorders: risk factors for unipolarity versus bipolarity. J Affect Disord 74: 173-184.
133. Modell S, Lauer CJ, Schreiber W, Huber J, Krieg JC, Holsboer F (1998). Hormonal response pattern in the combined DEX-CRH test is stable over time in subjects at high familial risk for affective disorders. Neuropsychopharmacology 18: 253-262.
134. Modell S, Yassouridis A, Huber J, Holsboer F (1997). Corticosteroid receptor function is decreased in depressed patients. Neuroendocrinology 65: 216-222.
135. Moreno FA, Rowe DC, Kaiser B, Chase D, Michaels T, Gelernter J et al (2002). Association between a serotonin transporter promoter region polymorphism and mood response during tryptophan depletion. Mol Psychiatry 7: 213-216.
136. Muller M, Holsboer F, Keck ME (2002). Genetic modification of corticosteroid receptor signalling: novel insights into pathophysiology and treatment strategies of human affective disorders. Neuropeptides 36: 117-131.
137. Murck H, Nickel T, Kunzel H, Antonijevic IA, Schill J, Zobel A et al (2003). State markers of depression in sleep EEG: dependency on drug and gender in patients treated with tianeptine or paroxetine. Neuropsychopharmacology 28: 348-358.
138. Murphy FC, Sahakian BJ, Rubinsztein JS, Michael A, Rogers RD, Robbins TW et al (1999). Emotional bias and inhibitory control processes in mania and depression. Psychol Med 29: 1307-1321.
139. Murphy FC, Smith KA, Cowen PJ, Robbins TW, Sahakian BJ (2002). The effects of tryptophan depletion on cognitive and affective processing in healthy volunteers. Psychopharmacology (Berl) 163: 42-53.
140. Nathan PJ, Stough C (2001). Inspection time: a neuropsychophysiological test for measuring the functional integrity of the cholinergic system. Med Hypotheses 57: 759-760.
141. Nelson JC, Charney DS (1981). The symptoms of major depressive illness. Am J Psychiatry 138: 1-13.
142. Nemeroff CB (1996). The corticotropin-releasing factor (CRF) hypothesis of depression: new findings and new directions. Mol Psychiatry 1: 336-342.
143. Nemeroff CB, Owens MJ, Bissette G, Andorn AC, Stanley M (1988). Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims. Arch Gen Psychiatry 45: 577-579.
144. Nemeroff CB, Widerlov E, Bissette G, Walleus H, Karlsson I, Eklund K et al (1984). Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. Science 226: 1342-1344.
145. Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, Gold SJ, Monteggia LM (2002). Neurobiology of depression. Neuron 34: 13-25.
146. Nestler EJ, Barrot M, Self DW (2001). DeltaFosB: a sustained molecular switch for addiction. Proc Natl Acad Sci USA 98: 11042-11046.
147. Neumeister A, Bain E, Nugent AC, Carson RE, Bonne O, Luckenbaugh DA et al (2004). Reduced serotonin type IA receptor binding in panic disorder. J Neurosci 24: 589-591.
148. Neumeister A, Konstantinidis A, Stastny J, Schwarz MJ, Vitouch O, Willeit M et al (2002). Association between serotonin transporter gene promoter polymorphism (5HTTLPR) and behavioral responses to tryptophan depletion in healthy women with and without family history of depression. Arch Gen Psychiatry 59: 613-620.
149. Neumeister A, Turner EH, Matthews JR, Postolache TT, Barnett RL, Rauh M et al (1998). Effects of tryptophan depletion vs catecholamine depletion in patients with seasonal affective disorder in remission with light therapy. Arch Gen Psychiatry 55: 524-530.
150. Nofzinger EA, Nichols TE, Meltzer CC, Price J, Steppe DA, Miewald JM et al (1999). Changes in forebrain function from waking to REM sleep in depression: preliminary analyses of [18F]FDG PET studies. Psychiatry Res 91: 59-78.
151. Odagaki Y, Garcia-Sevilla JA, Huguelet P, La Harpe R, Koyama T, Guimon J (2001). Cyclic AMP-mediated signaling components are upregulated in the prefrontal cortex of depressed suicide victims. Brain Res 898: 224-231.
152. Öngür D, Drevets WC, Price JL (1998). Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci USA 95: 13290-13295.
153. Oquendo MA, Barrera A, Ellis SP, Li S, Burke AK, Grunebaum M et al (2004). Instability of symptoms in recurrent major depression: a prospective study. Am J Psychiatry 161: 255-261.
154. Parker G (2000). Classifying depression: should paradigms lost be regained? Am J Psychiatry 157: 1195-1203.
155. Petronis A (2001). Human morbid genetics revisited: relevance of epigenetics. Trends Genet 17: 142-146.
156. Petronis A, Gottesman II, Kan P, Kennedy JL, Basile VS, Paterson AD et al (2003). Monozygotic twins exhibit numerous epigenetic differences: clues to twin discordance? Schizophr Bull 29: 169-178.
157. Pizzagalli DA, Oakes TR, Fox AS, Chung MK, Larson CL, Abercrombie HC et al (2004). Functional but not structural subgenual prefrontal cortex abnormalities in melancholia. Mol Psychiatry 9: 325.
158. Raadsheer FC, Hoogendijk WJ, Stam FC, Tilders FJ, Swaab DF (1994). Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. Neuroendocrinology 60: 436-444.
159. Rao U, Dahl RE, Ryan ND, Birmaher B, Williamson DE, Rao R et al (2002). Heterogeneity in EEG sleep findings in adolescent depression: unipolar versus bipolar clinical course. J Affect Disord 70: 273-280.
160. Redei EE, Ahmadiyeh N, Baum AE, Sasso DA, Slone JL, Solberg LC et al (2001). Novel animal models of affective disorders. Semin Clin Neuropsychiatry 6: 43-67.
161. Riedel WJ, Klaassen T, Schmitt JA (2002). Tryptophan, mood, and cognitive function. Brain Behav Immun 16: 581-589.
162. Riemann D, Berger M, Voderholzer U (2001). Sleep and depression - results from psychobiological studies: an overview. Biol Psychol 57: 67-103.
163. Riemann D, Hohagen F, Krieger S, Gann H, Muller WE, Olbrich R et al (1994). Cholinergic REM induction test: muscarinic supersensitivity underlies polysomnographic findings in both depression and schizophrenia. J Psychiatr Res 28: 195-210.
164. Rogers MA, Bradshaw JL, Phillips JG, Vaddadi K, Presnel I, Mileshkin C (2000). Parkinsonian motor characteristics in unipolar major depression. J Clin Exp Neuropsychol 22: 232-244.
165. Rogers RD, Tunbridge EM, Bhagwagar Z, Drevets WC, Sahakian BJ, Carter CS (2003). Tryptophan depletion alters the decision-making of healthy volunteers through altered processing of reward cues. Neuropsychopharmacology 28: 153-162.
166. Roiser JP, Rubinsztein JS, Sahakian BJ (2003). Cognition in depression. In: Spilberg H (eds). Psychiatry. Medicine Publishing Company: Abingdon.
167. Salomon RM, Miller HL, Krystal JH, Heninger GR, Charney DS (1997). Lack of behavioral effects of monoamine depletion in healthy subjects. Biol Psychiatry 41: 58-64.
168. Semont A, Fache M, Ouafik L, Hery M, Faudon M, Hery F (1999). Effect of serotonin inhibition on glucocorticoid and mineralocorticoid expression in various brain structures. Neuroendocrinology 69: 121-128.
169. Sen S, Nesse RM, Stoltenberg SF, Li S, Gleiberman L, Chakravarti A et al (2003). A BDNF coding variant is associated with the NEO personality inventory domain neuroticism, a risk factor for depression. Neuropsychopharmacology 28: 397-401.
170. Sheline YI (2003). Neuroimaging studies of mood disorder effects on the
171. Sheline YI, Mintun MA (2002). Structural and functional imaging of affectie disorders In: Nemeroff CB (eds). Neuropsychopharmacology: The Fifth Generation of Progress. Lippincott Williams & Wilkins: Philadelphia, PA. pp 1065-1080.
172. Sheline YI, Sanghavi M, Mintun MA, Gado MH (1999). Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression. J Neurosci 19: 5034-5043.
173. Shirayama Y, Chen AC, Nakagawa S, Russell DS, Duman RS (2002). Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J Neurosci 22: 3251-3261.
174. Siegle GJ, Konecky RO, Thase ME, Carter CS (2003). Relationships between amygdala volume and activity during emotional information processing tasks in depressed and never-depressed individuals: an fMRI investigation. Ann NY Acad Sci 985: 481-484.
175. Sobin C, Sackeim HA (1997). Psychomotor symptoms of depression. Am J Psychiatry 154: 4-17.
176. Stroud LR, Salovey P, Epel ES (2002). Sex differences in stress responses: social rejection versus achievement stress. Biol Psychiatry 52: 318-327.
177. Stunkard AJ, Fernstrom MH, Price A, Frank E, Kupfer DJ (1990). Direction of weight change in recurrent depression. Consistency across episodes. Arch Gen Psychiatry 47: 857-860.
178. Sullivan PF, Neale MC, Kendler KS (2000). Genetic epidemiology of major depression: review and meta-analysis. Am J Psychiatry 157: 1552-1562.
179. Sullivan RM, Gratton A (1999). Lateralized effects of medial prefrontal cortex lesions on neuroendocrine and autonomic stress responses in rats. J Neurosci 19: 2834-2840.
180. Taheri S, Mignot E (2002). The genetics of sleep disorders. Lancet Neurol 1: 242-250.
181. Timpl P, Spanagel R, Sillaber I, Kresse A, Reul JM, Stalla GK et al (1998). Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1. Nat Genet 19: 162-166.
182. Toczek MT, Carson RE, Lang L, Ma Y, Spanaki MV, Der MG et al (2003). PET imaging of 5-HT1A receptor binding in patients with temporal lobe epilepsy. Neurology 60: 749-756.
183. Toh KL, Jones CR, He Y, Eide EJ, Hinz WA, Virshup DM et al (2001). An hPer2 phosphorylation site mutation in familial advanced sleep phase syndrome. Science 291: 1040-1043.
184. Tremblay LK, Naranjo CA, Cardenas L, Herrmann N, Busto UE (2002). Probing brain reward system function in major depressive disorder: altered response to dextroamphetamine. Arch Gen Psychiatry 59: 409-416.
185. Trichard C, Martinot JL, Alagille M, Masure MC, Hardy P, Ginestet D et al (1995). Time course of prefrontal lobe dysfunction in severely depressed in-patients: a longitudinal neuropsychological study. Psychol Med 25: 79-85.
186. Tsourtos G, Thompson JC, Stough C (2002). Evidence of an early information processing speed deficit in unipolar major depression. Psychol Med 32: 259-265.
187. Tsuang MT, Faraone SV, Lyons MJ (1993). Identification of the phenotype in psychiatric genetics. Eur Arch Psychiatry Clin Neurosci 243: 131-142.
188. Wang GJ, Volkow ND, Logan J, Pappas NR, Wong CT, Zhu W et al (2001). Brain dopamine and obesity. Lancet 357: 354-357.
189. Watkins PC, Vache K, Verney SP, Muller S, Mathews A (1996). Unconscious mood-congruent memory bias in depression. J Abnorm Psychol 105: 34-41.
190. Young EA (1998). Sex differences and the HPA axis: implications for psychiatric disease. J Gend Specif Med 1: 21-27.
191. Young EA, Lopez JF, Murphy-Weinberg V, Watson SJ, Akil H (2003). Mineralocorticoid receptor function in major depression. Arch Gen Psychiatry 60: 24-28.
192. Zetterstrom TS, Pei Q, Madhav TR, Coppell AL, Lewis L, Grahame-Smith DG (1999). Manipulations of brain 5-HT levels affect gene expression for BDNF in rat brain. Neuropharmacology 38: 1063-1073.
193. Zobel AW, Nickel T, Kunzel HE, Acid N, Sonntag A, Ising M et al (2000). Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated. J Psychiatr Res 34: 171-181.
194. Zobel AW, Yassouridis A, Frieboes RM, Holsboer F (1999). Prediction of medium-term outcome by cortisol response to the combined dexamethasone-CRH test in patients with remitted depression. Am J Psychiatry 156: 949-951.
195. Zubenko GS, Hughes III HB, Maher BS, Stiffler JS, Zubenko WN, Marazita ML (2002). Genetic linkage of region containing the CREB1 gene to depressive disorders in women from families with recurrent, early-onset, major depression. Am J Med Genet 114: 980-987.